Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”

814 views

Published on

Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced . In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”

  1. 1. IQ4I Research & Consultancy Pvt. Ltd. Page 1 Next-Generation Sequencing (NGS) Global Market –Forecast to 2022 Next-generation Sequencing (NGS) Global Market estimated to be worth $14,722.5 million by 2022 IQ4I Research & Consultancy published a new report on “Next-Generation Sequencing (NGS) Global Market – Forecast To 2022” This report analyzes and studies the overall market, major drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World IQ4I’s Report Contains 112 market data tables and 69 figures spread through 375 pages and an exhaustive TOC on “Next-Generation Sequencing (NGS) Global Market [Technology (Reversible terminator Sequencing, Ion-Semiconductor sequencing, Sequencing by Ligation, Single-Molecule Real-time (SMRT) Sequencing and others), Products (Instruments, Services and Work-flow products), , Application (By Process and By field) (By Process- Genomics, Epigenomics, Transcriptomics and Others & By field- Diagnostics, Drug discovery and development, Biomarker discovery, Agriculture and animal research and Others), End-Users (Academic Research, Hospitals and clinics, Biotech/Pharmaceuticals and Others) Region [(North America (U.S. and Others), Europe (U.K., Germany, Spain and Others), APAC(South Korea, China, Australia and others) and ROW(Brazil, South Africa, Middle East and Others)] This report analyzes the Next-Generation Sequencing global market in terms of market revenue ($ million) for all segments and it enables Next-Generation Sequencing stakeholders such as NGS service providers, diagnostic testing and monitoring service centers, clinical laboratories & hospitals, pharma & biotech Companies, Various research and consulting firms to identify and analyze market expansion opportunities, technological advancements and competition in Next-Generation Sequencing global market. Next-generation sequencing refers to modern non-Sanger-based high-throughput DNA sequencing technologies that can sequence millions or billions of DNA strands in parallel, yielding substantially more throughput and minimizing the need for the time consuming fragment-cloning methods that are often used in Sanger sequencing of genomes. Next- generation sequencing market is a fast emerging market with a high growth rate, as estimated by IQ4I Research that the Next-generation sequencing global market are expected to grow at a high double-digit CAGR from 2015-2022. Reduced cost and high speed of NGS technology, increased usage in the clinical segment, new application areas of NGS and switch over from microarrays to NGS, are expected to propel the growth of next-generation sequencing market. However some issues like standardization of NGS for clinical use, complexity in data interpretation, shortage of skilled
  2. 2. IQ4I Research & Consultancy Pvt. Ltd. Page 2 Next-Generation Sequencing (NGS) Global Market –Forecast to 2022 labor and dependence on grants and funding for NGS infrastructure may hinder the growth of next-generation sequencing market. The Next-generation sequencing global market by technology is segmented into Reversible terminator sequencing, Ion semi-conductor sequencing, Sequencing by Ligation (SBL), Single-Molecule Real-time (SMRT) Sequencing and others. The Reversible terminator sequencing occupied highest market in Next-generation sequencing technology market. The Next-generation sequencing global market by products is segmented into Instruments, Services and Work-flow products. The services market is further segmented into Data analysis services and Sequencing Services. The Services segment is estimated to grow at strong CAGR from 2015 to 2022. The Next-generation sequencing global market by Application is segmented based on process and field of application. By process, the market is segmented into Genomics, Epigenomics, Transcriptomics and others. Genomics application is further segmented into Whole genome sequencing, Exome sequencing, Targeted sequencing and De Novo sequencing). Epigenomics market is further segmented into ChiP sequencing and Methylation sequencing). By field of application, the market is segmented into Diagnostics, Drug discovery and development, Biomarker discovery, Agriculture and animal research and others. Diagnostics application is further segmented into Cancer diagnostics, Infectious disease diagnostics, Genetic analysis and Transplantation diagnostics. The Diagnostics application occupied highest market in Next-generation sequencing application market. The End-users consists of Academic Research, Hospitals and clinics, Biotech/Pharmaceuticals and Others. The Academic Research contributed the largest revenue as per estimates of IQ4I Research. The Next-generation sequencing global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue in 2015 due to advanced technological healthcare framework, rise in growth of personalized medicine, increasing incidence of infectious disease and cancer, high R&D investment for genomic and proteomic sequence determination for biomarker and drug discovery research. Some of the prominent players in next-generation sequencing market include Agilent Technologies (U.S.), BGI (China), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Qiagen N.V. (Netherlands), Oxford Nanopore Technologies Ltd. (U.K.), Eurofins
  3. 3. IQ4I Research & Consultancy Pvt. Ltd. Page 3 Next-Generation Sequencing (NGS) Global Market –Forecast to 2022 Scientific (U.K.), Roche holdings AG (Switzerland), DNASTAR, Inc. (U.S.), Thermo Fischer Scientific, Inc.(U.S). Reasons for buying this report:  Analysis of the Next-generation sequencing global market by identifying various segments by technology, product type, applications, end users and geography.  Revenue forecast of the Next-generation sequencing market and strategic analysis of each submarket with respect to segmental growth trends.  Analysis of the major market trends and factors driving or inhibiting the growth of the Next-generation sequencing global market.  Revenue forecast of the NGS market with respect to North America (U.S. and others), Europe (U.K., Germany, Spain and Others), Asia-Pacific (China, South Korea, Australia and others) and the Rest of the World (RoW) (Brazil, Middle East, South Africa and Others).  Analysis of the opportunities for stakeholders by identifying the high-growth segments of the market.  Analysis of country wise installation base.  Identification of key technology developments and innovations driving the market.  Profiles of major players in the next-generation sequencing global market with details of their product offerings, business strategies, market shares and patent application filing trends.  Established and Emerging players (47 companies) and their product offerings.
  4. 4. IQ4I Research & Consultancy Pvt. Ltd. Page 4 Next-Generation Sequencing (NGS) Global Market –Forecast to 2022 FIGURE 1 NEXT-GENERATION SEQUENING GLOBAL MARKET SEGMENTATION Next-Generation Sequencing (NGS) Global Market By Technique Reversible Terminator Sequencing By Product By End-Users Ion Semiconductor sequencing Sequencing by Ligation Instruments Work flow products Academic research Hospitals Biotech/Pharma SMRTSequencing Others Services DataAnalysis Services Sequencing Services By Application By processBy Field Diagnostics Drug Discovery & Development Biomarker discovery Agriculture & animal health Others Epigenomics Genomics Transcriptomics Others Cancer diagnostics Transplant dgx Genetic analysis Infectious diseases WGS Targeted sequencing Exome sequencing De-novo sequencing Methyl sequencing ChIP Sequencing Others

×